Page last updated: 2024-09-05

sb 203580 and carboplatin

sb 203580 has been researched along with carboplatin in 1 studies

Compound Research Comparison

Studies (sb 203580)	Trials (sb 203580)	Recent Studies (post-2010) (sb 203580)	Studies (carboplatin)	Trials (carboplatin)	Recent Studies (post-2010) (carboplatin)
3,489	4	1,137	12,895	4,001	5,244

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, H; Fu, Y; Han, X; Postovit, LM; Steed, H; Zhou, J	1

Other Studies

1 other study(ies) available for sb 203580 and carboplatin

Article	Year
Pharmacological Inhibition of p38 MAPK by SB203580 Increases Resistance to Carboplatin in A2780cp Cells and Promotes Growth in Primary Ovarian Cancer Cells. International journal of molecular sciences, 2018, Jul-26, Volume: 19, Issue:8 Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Humans; Imidazoles; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Tumor Cells, Cultured	2018

Article

Year

Pharmacological Inhibition of p38 MAPK by SB203580 Increases Resistance to Carboplatin in A2780cp Cells and Promotes Growth in Primary Ovarian Cancer Cells.

International journal of molecular sciences, 2018, Jul-26, Volume: 19, Issue:8

Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Humans; Imidazoles; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Tumor Cells, Cultured

2018